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Abstract: 
The relationship between Epstein-Barr virus (EBV) and the germinal centre (GC) of the asymptomatic 
host remains an enigma. The occasional appearance of EBV-positive germinal centres in some 
patients, particularly those with a history of immunosuppression, suggests that EBV numbers in the 
GC are subject to immune control. The relationship, if any, between lymphoid hyperplasia with EBV-
positive germinal centres and subsequent or concurrent lymphomagenesis remains to be clarified. 
As far as the development of EBV-associated Hodgkin's lymphoma is concerned, the suppression of 
virus replication, mediated by LMP1 on the one hand, and the loss of B-cell receptor signalling on 
the other, appears to be an important pathogenic mechanism. A further important emerging 
concept is that alterations in the microenvironment of the EBV-infected B-cell may be important for 
lymphomagenesis. 
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